rubidium has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerruti, L; Froelich, CJ; Jane, SM; Johnstone, RW; Ruefli, AA; Smyth, MJ; Tainton, KM | 1 |
1 other study(ies) available for rubidium and Leukemia, T-Cell
Article | Year |
---|---|
P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins.
Topics: Antibodies; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Humans; K562 Cells; Kinetics; Leukemia, T-Cell; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Receptors, IgG; Receptors, Transferrin; Recombinant Proteins; Rubidium; Transfection; Tumor Cells, Cultured; Vincristine | 2001 |